Chicago, Il., USA - August 28, 2014, Chicago, Il., USA - Durata Therapeutics, a pharmaceutical company, announced that Wendy Yarno and Marty Carroll were added to its board of directors.
Article continues below
Ms. Yarno held positions of increasing responsibility and was responsible for leading multiple business groups during her 26-year career at Merck & Co, Inc. Most recently, she served as Executive Vice President and Chief Marketing Officer where she led the global organization of more than 3,000 individuals responsible for supporting product commercialization across more than 20 therapeutic areas.
Ms. Yarno also served as Merck's Senior Vice President of Human Resources, where her successful efforts to develop and implement new corporate personnel strategies proved transformative for this key business function. She was also Vice President of Johnson & Johnson, Ortho McNeil Pharmaceutical's highly profitable Women's Health Care Franchise.
Ms. Yarno received an M.B.A. from the Fox School of Business at Temple University and a B.S. in business administration from Portland State University. She also serves on the Board of Directors for St. Jude Medical, Medivation, and Aratana Therapeutics.
Mr. Carroll served as President and Chief Executive Officer of Boehringer Ingelheim Corporation (US) from 2003 until 2011. He also served as Global Head of Corporate Strategy and Development for Boehringer Ingelheim (Germany) from 2009 through 2012. In addition, Mr. Carroll served as Chairman of the Board for a number of Boehringer Ingelheim companies in the US from 2002 to 2012.
Previously, he held positions of increasing responsibility with Merck & Co., Inc. from 1976 to 2001 including Manufacturing, International (Japan), and Marketing and Sales. At the time he left Merck, he was serving as its Executive Vice President, Customer Marketing and Sales of Merck's US Human Health Division. From 1972 to 1976, he served in the United States Air Force.
Mr. Carroll has previously served on the Board of Directors for Accredo Health, Gwynedd Mercy College, as well as PhRMA. He currently serves as a director of Mallinckrodt Plc. He received a B.A. in accounting and economics from the College of the Holy Cross and a M.B.A. from Babson College. ■